Biologics, including cell and gene therapies, have become a hot topic in the pharmaceutical industry as their therapeutic applications expand. Challenges of developing biologic drug products include scale-up for commercial manufacturing and production at a high enough purity for effective medical applications. Thus, it is critical to examine the biomanufacturing steps that produce biologic drug products in order to optimize the process for the necessary production scale without losing quality and purity.

Read More